Section Nineteen Thermoregulation
PROCEDURE 147 Measures to Reverse Hyperthermia
PROCEDURE 148 Measures to Reverse Hypothermia
PROCEDURE 150 Forced Air Warming Blanket
PROCEDURE 151 Warm/Cool Water–Circulating Blankets
PROCEDURE 147 Measures to Reverse Hyperthermia
INDICATION
To lower body temperature to 39° C (102° F) or less through rapid cooling in patients whose temperatures are greater than 40.5° C (105° F). Hyperthermia may result from fever, heatstroke, metabolic disorders, thermoregulatory dysfunction, medications (e.g., malignant hyperthermia, neuroleptic malignant syndrome [NMS]), or drugs of abuse (cocaine, amphetamine derivatives) (Erickson & Prendergast, 2004). The best treatment is prevention—providing proper clothing, administering fluid and salt replacement, or moving to a cool, shady environment.
CONTRAINDICATIONS AND CAUTIONS
1. Cooling must be initiated immediately on the discovery of a hyperthermic state and must proceed rapidly. For a successful outcome, temperatures must be decreased to 39° C (102° F) or below within 1 hour of initiating treatment (Erickson & Prendergast, 2004).
2. Antipyretics are ineffective in lowering the body temperature and may result in additional complications, such as coagulopathy and hepatic damage (Erickson & Prendergast, 2004).
3. Initial diagnosis is often difficult. Early symptoms of significant heat illness are usually nonspecific (drowsiness, confusion, headache) and may be overlooked or attributed to other causes. The key to diagnosis is a history of a related incident (Schmidt & Nichols, 2005).
4. Do not sponge the patient with alcohol because it may be absorbed transcutaneously with resultant toxicity (Hadad Rav-Acha, Heled, Epstein, & Moran, 2004).
PATIENT PREPARATION
1. Place the patient on high-flow oxygen because oxygen demand is increased in the hyperthermic state (see Procedure 25). Using cool aerosol mist may moderate body temperature and minimize fluid loss due to rapid respiratory rate.
2. Initiate an intravenous line to restore intravascular volume (see Procedure 60).
3. Initiate additional resuscitative efforts as indicated.
4. Place the patient on a cardiac monitor because nonspecific ST-segment changes, conduction disturbances, and ventricular arrhythmias have been reported during cooling (see Procedure 55).
5. Draw blood for complete blood count, potassium, sodium, phosphorus, calcium, magnesium, prothrombin time and partial thromboplastin time, blood urea nitrogen, glucose, creatinine, liver function tests, and creatine phosphokinase determinations (see Procedure 58).
6. Remove all of the patient’s clothing.
7. Establish continuous temperature monitoring. Urinary bladder, rectal, or esophageal probes are options. Check the rectum for stool before placement of a rectal probe; if the probe is placed in feces, the reading is inaccurate.
8. Obtain a baseline 12-lead electrocardiogram (see Procedure 56).
9. Insert a urinary bladder catheter to monitor fluid output (see Procedure 104).
PROCEDURAL STEPS
A variety of modalities may be used for rapid cooling, depending on the patient’s condition, the availability of resources, and the institutional protocols. The most effective are evaporative cooling or immersion in ice water (Erickson & Prendergast, 2004). Options include the following:
1. Evaporative cooling. Cover the patient with wet towels or spray the patient with water while circulating air around the patient with large fans to promote heat loss through evaporation. The latter method is preferred because of rapid heat loss, availability of supplies, and easy access to the patient.
2. Immersion in ice water is effective but logistically more difficult and adds the danger of injury or airway hazard because of the patient’s altered mental status in circumstances where rescue is hampered. Also, while the body heat is transferred to the cooler water, the coolness may induce peripheral vasoconstriction that shunts blood flow to the body core lowering the rate of transfer. Sponging the patient with ice water may be tried initially. If initial cooling efforts are not rapidly effective, ice water immersion may be undertaken.
3. Cover the patient with a cooling blanket (controversial and slow) (see Procedure 151).
4. Apply ice packs to the neck, axilla, and inguinal area. Place a dry interface between the skin and the cold pack. Monitor the underlying skin for cold injury. This method is less effective than immersion in ice water.
5. Administer dantrolene as prescribed for malignant hyperthermia or NMS. Dantrolene is not effective in environmental hyperthermia.
6. Internal methods of cooling may be necessary in the patient with severe hyperthermia or who does not respond to external methods. Internal methods include cold peritoneal lavage (see Procedure 95), cold gastric lavage (see Procedure 99), and cardiopulmonary bypass (Vicario, 2006).
7. Stop cooling at 39° C (102.2° F) because the body temperature continues to drift downward, and hypothermia may result if cooling measures are continued beyond this point.
AGE-SPECIFIC CONSIDERATIONS
1. Both the elderly and the very young are at risk for classic hyperthermia because of decreased thermoregulatory functioning. The elderly have a relative inability to adapt to environmental temperatures, a decreased ability to perspire, and other chronic medical conditions that affect their ability to acclimate to warmer temperatures. Dependent elderly persons are at increased risk due to inadequate fluid intake, poor ability to make their needs known, and medicines that inhibit thermoregulation. Institutionalized elderly persons at facilities with high staffing ratios or staff shortage are especially at risk. The very young have a shorter stature, placing them closer to radiated heat from asphalt or cement; have fewer sweat glands; and are more easily dehydrated.
2. Young adults (e.g., athletes, outdoor laborers, military personnel) are at risk for exertional hyperthermia. Education on prevention and early treatment should be provided to leaders of such groups. During periods of unusual heat stress weather, public service announcements should be made regarding prevention, early treatment, and EMS access.
3. Patients taking psychotropic medicines and anticholinergics are at risk for impaired thermoregulation.
COMPLICATIONS
1. Violent shivering with rapid cooling, which may result in further heat production. Shivering can be controlled by the use of benzodiazepines (Erickson & Prendergast, 2004).
6. Frostbite caused by ice packs
7. Rhabdomyolysis in severe exertional hyperthermia
8. Disseminated intravascular coagulation
9. Hypothermia from overly vigorous cooling
Erickson T., Prendergast H. Procedures pertaining to hypothermia. In: Roberts J.R., Hedges J.R. Clinical procedures in emergency medicine. 4th ed. Philadelphia: Saunders; 2004:1343–1357.
Hadad E., Rav-Acha M., Heled Y., Epstein Y., Moran D.S. Heat stroke: A review of cooling methods. Sports Medicine. 2004;34:501–511.
Schmidt E.W., Nichols C.G. Heat-related illness. In: Wolfson A.B., ed. Harwood-Nuss’ clinical practice of emergency medicine. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005:1757–1760.
Vicario S. Heat illness. In: Marx J., Hockberger R.S., Walls R.M. Rosen’s emergency medicine: Concepts and clinical practice. 6th ed. St. Louis: Mosby; 2006:2254–2267.
PROCEDURE 148 Measures to Reverse Hypothermia
CONTRAINDICATIONS AND CAUTIONS
1. Hypothermia creates myocardial irritability, so patients must be handled gently and procedures performed cautiously because stimulation may precipitate ventricular fibrillation. The risk is highest at temperatures below 29° C (85.2° F) (AHA, 2005; Chang, 2005).
2. With active external rewarming, patients may experience rewarming shock, which is evidenced by a decrease in blood pressure resulting from vasodilation in previously vasoconstricted extremities.
3. With active external rewarming, patients may experience a temperature afterdrop, which results from the shunting of cold blood from extremities to the core, which further chills the myocardium and increases the potential for ventricular fibrillation. This phenomenon occurs infrequently and appears to be of little clinical significance (Ulrich & Rathlev, 2004).
4. Medications must be used judiciously because most drugs have little effect on the hypothermic patient and may cause complications on rewarming because of delayed metabolism of drugs (e.g., metabolic alkalosis with sodium bicarbonate, hypoglycemia with insulin).
5. Skin should not be massaged or rubbed, and alcohol should not be used on the skin of hypothermic patients; these techniques increase vasodilation and move cold blood from the extremities to the core.
6. Attempts at defibrillation are usually unsuccessful until core temperature is above 28° to 30° C (82° to 86° F) (Chang, 2005). The American Heart Association suggests that with severe hypothermia, defibrillation should be attempted once and then active internal rewarming should be instituted (AHA, 2005).
EQUIPMENT
PATIENT PREPARATION
1. Remove the patient from the cold or wet environment. Remove all clothing, dry the patient, and place the patient on a stretcher covered with sheets or blankets to prevent heat loss via conduction. Long hair should be dried or positioned away from the patient’s head.
2. Initiate resuscitation as indicated for the patient in cardiac arrest. Endotracheal intubation is necessary unless the patient is alert and has intact protective airway reflexes. Preoxygenate the patient before intubation to avoid dysrhythmias. Factors precipitating dysrhythmias during intubation are rough technique, hypoxia, and acid-base abnormalities (Chang, 2005; Erickson & Prendergast, 2004).
3. Establish continuous temperature monitoring. Urinary bladder, rectal, or esophageal probes are options. Check the rectum for stool before placement of a rectal probe; if the probe is placed in feces, the reading is inaccurate.
4. Apply the cardiac monitor for ongoing assessment during the rewarming procedures (see Procedure 55).
5. Obtain a baseline 12-lead electrocardiogram (see Procedure 56).
6. Perform a bedside blood glucose test (see Procedure 59). Obtain blood for complete blood count, arterial blood gases (uncorrected for temperature) (see Procedure 19), potassium, glucose, calcium, magnesium, prothrombin time and partial thromboplastin time, fibrinogen, fibrin split products, amylase, lipase, blood urea nitrogen, and creatinine determinations (see Procedure 58).
PROCEDURAL STEPS
There are three methods of rewarming: passive external rewarming (PER), active external rewarming (AER), and active core rewarming (ACR). The recommended rewarming methods are as follows (AHA, 2005; Ulrich & Rathlev, 2004):
Mild hypothermia | 34° to 36° C (93.2° to 96.8° F) | PER, AER |
Moderate hypothermia | 30° to 34° C (86° to 93.2° F) | PER, AER (truncal areas only) |
Severe hypothermia | Below 30° C (86° F) | ACR |
Passive External Rewarming (PER)
1. Cover the patient with blankets to prevent heat loss from radiation and convection. Be sure to cover the head because a significant amount of heat is lost from an uncovered head.
2. If IV fluids are indicated, they should be warmed before administration to assist with rewarming and prevent further heat loss.
Active External Rewarming (AER)
The current recommendation is to heat only the thorax during AER of the moderately hypothermic patient and leave the extremities unheated to allow for the maintenance of peripheral vasoconstriction, thus preventing temperature afterdrop and rewarming shock (Chang, 2005).